Cite
MLA Citation
José R. González-Juanatey et al.. “Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition.” Expert review of clinical pharmacology, vol. 13, no. 7, 2020, pp. 695–706. http://access.bl.uk/ark:/81055/vdc_100159073748.0x00000d